Mitochondrial disorders

Current Neurology and Neuroscience Reports

Volumn 3, Issue 5, 2003, Pages 423-432

  Zeviani, Massimo ^a   Spinazzola, Antonella ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; IDEBENONE; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; CYTOCHROME C OXIDASE; UBIQUINOL CYTOCHROME C REDUCTASE;

BIOGENESIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY YIELD; GENE MUTATION; GENE THERAPY; GENETICS; GENOTYPE PHENOTYPE CORRELATION; MEDICAL GENETICS; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PUBLICATION; REVIEW; YEAST; ANIMAL; HUMAN; MUTATION;

ANIMALS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX III; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIAL DISEASES; MUTATION;

EID: 0642305675     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0026-9     Document Type: Review

References (65)

1. Shanske S, Tang Y, Hirano M, et al.: Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with pearson syndrome. Am J Hum Genet 2002, 71:679-683.
2. Schwartz M and Vissing J: Paternal inheritance of mtDNA. N Engl J Med 2002, 347:576-580.
3. Battersby BJ, Loredo-Osti JC, Shoubridge EA: Nuclear genetic control of mitochondrial DNA segregation. Nat Genet 2003, 33:183-186.
4. Yang MY, Bowmaker M, Reyes A, et al.: Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. Cell 2002, 111:495-505.
5. Falkenberg M, Gaspari M, Rantanen A, et al.: Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 2002, 31:289-294.
6. Crimi M, Sciacco M, Galbiati S, et al.: A collection of 33 novel human mtDNA homoplasmic variants. Hum Mutat 2002, 20:409-0.
7. He L, Chinnery PF, Durham SE, et al.: Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 2002, 30:e68.
8. Choo-Kang AT, Lynn S, Taylor GA, et al.: Defining the importance of mitochondrial gene defects in maternally inherited diabetes by sequencing the entire mitochondrial genome. Diabetes 2002, 51:2317-20.
9. Corona P, Lamantea E, Greco M, et al.: Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol 2002, 51:118-122.
10. Lamantea E, Carrara F, Mariotti C, et al.: A novel nonsense mutation (Q352X) in the mitochondrial cytochrome b gene associated with a combined deficiency of complexes I and III. Neuromuscul Disord 2002, 12:49-52.
11. Taylor RW, Schaefer AM, McFarland R, et al.: A novel mitochondrial DNA tRNA(Ile) (A4267G) mutation in a sporadic patient with mitochondrial myopathy. Neuromuscul Disord 2002, 12:659-664.
12. Sacconi S, Salviati L, Sue CM, et al.: Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res 2003, 53:224-230.
13. Valentino ML, Avoni F, Barboni P, et al.: Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber's hereditary optic neuropathy. Ann Neurol 2002, 51:774-778.
14. McFarland R, Clark KM, Morris AA, et al.: Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002, 30:145-146.
15. Funalot B, Reynier P, Vighetto A, et al.: Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Ann Neurol 2002, 52:374-377.
16. Taylor RW, Morris AA, Hutchinson M, et al.: Leigh disease associated with a novel mitochondrial DNA ND5 mutation. Eur J Hum Genet 2002, 10:141-144.
17. Horvath R, Scharfe C, Hoeltzenbein M, et al.: Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene. J Med Genet 2002, 39:812-816.
18. Chol M, Lebon S, Benit P, et al.: The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 2003, 40:188-191.
19. Zhang J, Asin-Cayuela J, Fish J, et al.: Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci U S A 2003, 100:1116-1121.
20. Wang Y, Michikawa Y, Mallidis C, et al.: Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A 2001, 98:4022-4027.
21. Fayet G, Jansson M, Sternberg D, et al.: Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromusc Disord 2002, 12:484-493.
22. Chinnery PF, Samuels DC, Elson J, Turnbull DM: Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet 2002, 360:1323-1325.
23. Suzuki T, Suzuki T, Wada T, et al.: Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J 2002, 21:6581-6589.
24. Feuermann M, Francisci S, Rinaldi T, et al.: The yeast counterparts of human 'MELAS' mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep 2003, 4:53-58.
25. Qi X, Lewin AS, Hauswirth WW, Guy J: Suppression of complex I gene expression induces optic neuropathy. Ann Neurol 2003, 53:198-205.
26. Qi X, Lewin AS, Hauswirth WW, Guy J: Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Oplithalmol Vis Sci 2003, 44:1088-1096.
27. Wredenberg A,Wibom R, Wilhelmsson H, et al.: Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A 2002, 99:15066-15071.
28. Man PY, Griffiths PG, Brown DT, et al.: The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 2003, 72:333-339.
29. Taivassalo T, Jensen TD, Kennaway N, et al.: The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain 2003, 126:413-423.
30. Wolf NI, Smeitink JA: Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology 2002, 59:1402-1405.
31. Janssen R, Smeitink J, Smeets R, van Den Heuvel L: CIA30 complex I assembly factor: a candidate for human complex I deficiency? Hum Genet 2002, 110:264-270.
32. Rustin P, Rotig A: Inborn errors of complex II - unusual human mitochondrial diseases. Biochim Biophys Acta 2002, 1553:117-122.
33. Maher ER, Eng C: The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 2002, 11:2347-2354.
34. Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic phaeochromocytoma. N Engl J Med 2002, 346:1459-1466.
35. Gimenez-Roqueplo AP, Favier J, Rustin P, et al.: Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab 2002, 87:4771-4774.
36. Tomlinson IP, Alam NA, Rowan AJ, et al.: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002, 30:406-410.
37. Van Maldergem L, Trijbels F, DiMauro S, et al.: Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 2002, 52:750-754.
38. Barrientos A, Korr D, Tzagoloff A: Shy1p is necessary for full expression of mitochondrial COX1 in the yeast model of Leigh's syndrome. EMBO J 2002, 21:43-52.
39. Agostino A, Invernizzi F, Tiveron C, et al.: Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice. Hum Mol Genet 2003, 12:399-413.
40. Salviati L, Sacconi S, Rasalan MM, et al.: Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease. Arch Neurol 2002, 59:862-865.
41. Salviati L, Hernandez-Rosa E, Walker WF, et al.: Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem J 2002, 363:321-327.
42. Takahashi Y, Kako K, Kashiwabara S, et al.: Mammalian copper chaperone Cox17 has an essential role in activation of cytochrome c oxidase and embryonic development. Mol Cell Biol 2002, 22:7614-7622.
43. Antonicka H, Mattman A, Carlson CG, et al.: Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 2003, 72:101-114.
44. Visapaa I, Fellman V, Vesa J, et al.: GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 2002, 71:863-876.
45. Lamantea E, Tiranti V, Bordoni A, et al.: Mutations of mitochondrial DNA polymerase A are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002, 52:211-219.
46. Van Goethem G, Martin JJ, Dermaut B, et al.: Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003, 13:133-142.
47. Agostino A, Valletta L, Chinnery PF, et al.: Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003, 60:1354-1356.
48. Ponamarev MV, Longley MJ, Nguyen D, et al.: Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J Biol Chem 2002, 277:15225-15228.
49. Mancuso M, Salviati L, Sacconi S, et al.: Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology 2002, 59:1197-1202.
50. Salviati L, Sacconi S, Mancuso M, et al.: Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002, 52:311-317.
51. Spinazzola A, Marti R, Nishino I, et al.: Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002, 277:4128-4133.
52. Haraguchi M, Tsujimoto H, Fukushima M, et al.: Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol Cell Biol 2002, 22:5212-5221.
53. Rosenberg MJ, Agarwala R, Bouffard G, et al.: Mutant deoxynucleotide carrier is associated with congenital microcephaly. Nat Genet 2002, 32:175-179.
54. Kelley RI, Robinson D, Puffenberger EG, et al.: Amish lethal microcephaly: a new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria. Am J Med Genet 2002, 112:318-326.
55. Schlame M, Towbin JA, Heerdt PM, et al.: Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 2002, 51:634-637.
56. Valianpour F, Wanders RJ, Overmars H, et al.: Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J Pediatr 2002, 141:729-733.
57. De Lonlay P, Mugnier C, Sanlaville D, et al.: Cell complementation using Genebridge 4 human:rodent hybrids for physical mapping of novel mitochondrial respiratory chain deficiency genes. Hum Mol Genet 2002, 11:3273-3281.
58. Steinmetz LM, Scharfe C, Deutschbauer AM, et al.: Systematic screen for human disease genes in yeast. Nat Genet 2002, 31:400-404.
59. Mootha VK, Lepage P, Miller K, et al.: Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 2003, 100:605-610.
60. Komura K, Hobbiebrunken E, Wilichowski EK, Hanefeld FA: Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr Neurol 2003, 28:53-58.
61. Hausse AO, Aggoun Y, Bonnet D, et al.: Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 2002, 87:346-349.
62. Artuch R, Aracil A, Mas A, et al.: Friedreich's ataxia: idebenone treatment in early stage patients. Neuropediatrics 2002, 33:190-193.
63. Manfredi G, Fu J, Ojaimi J, et al.: Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 2002, 30:394-399.
64. Guy J, Qi X, Pallotti F, et al.: Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol 2002, 52:529-530.
65. Tanaka M, Borgeld HJ, Zhang J: Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria. J Biomed Sci 2002, 9:534-541.